Beatriz Marinho Silva Romão, Felipe Vieira Duval, Elisângela Costa Lima, Fabrício Alves Barbosa da Silva, & Guacira Correa de Matos. (2024). Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (FAERS). Frontiers Media S.A..
Chicago Style (17th ed.) CitationBeatriz Marinho Silva Romão, Felipe Vieira Duval, Elisângela Costa Lima, Fabrício Alves Barbosa da Silva, and Guacira Correa de Matos. Detection of Potential Safety Signals Related to the Use of Remdesivir and Tocilizumab in the COVID Era During Pregnancy, Resorting to Open Data from the FDA Adverse Event Reporting System (FAERS). Frontiers Media S.A., 2024.
MLA (9th ed.) CitationBeatriz Marinho Silva Romão, et al. Detection of Potential Safety Signals Related to the Use of Remdesivir and Tocilizumab in the COVID Era During Pregnancy, Resorting to Open Data from the FDA Adverse Event Reporting System (FAERS). Frontiers Media S.A., 2024.